There will be a Special Seminar on Monday, April 22nd at 2:00 PM in the Goldman International Conference Center. Our speaker will be Adam Telerman, MD, PhD, Research Director, Laboratory of Applied Biotechnology & Pharmacology, Ecole Normale Superieure, Cachan, France, who will present “Tumor reversion, the molecular program and the clinical applications”. Dr. Telerman will be co-hosted by Marc Symons, PhD and Lionel Blanc, PhD.
GOAL: The overall goal for the RSC (Regularly Scheduled Conference) is to inform physicians of new developments in understanding basic mechanisms of disease and novel therapeutics that capitalize on a deeper appreciation of disease pathophysiology.
OBJECTIVES: Program Objectives: Identify new developments in understanding mechanisms of disease. Integrate new investigational results with current diagnostic and treatment protocols. Judge the potential importance for current best practices of treatment regimens basic on new translational studies.
Target Audience: Physicians and research scientists/scientific staff.
CME ACCREDITATION:
North Shore – LIJ Health System is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.
DISCLOSURES: North Shore-LIJ Health System adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Dr.Telerman has no financial relationships to disclose.
CREDIT DESIGNATION STATEMENT: The North Shore – LIJ Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credittm. Each physician’s should only claim credit commensurate with the extent of their participation in the activity.
The post Special Seminar in Investigative Medicine appeared first on Feinstein Institute for Medical Research.